While the development of COVID-19 vaccines makes the need to store vaccines at low temperatures increasingly urgent, South Korea is proving to be less than prepared.
The new vaccines from US companies Pfizer and Moderna are based on messenger RNA (mRNA), and as a result, need to be stored at low temperatures — minus 70 degrees Celsius for Pfizer’s and minus 20 degrees Celsius for Moderna’s.